Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019

    Jayanthi Mathaiyan1, Prasanth Ganesan2, Tamilarasu Kadhiravan3, Nishanthi Anandabaskar4 Corresponding author

    1. 1Department of Pharmacology, JIPMER, Puducherry, India.
    2. 2Department of Medical Oncology, JIPMER, Puducherry, India.
    3. 3Department of Medicine, JIPMER, Puducherry, India.
    4. 4Department of Pharmacology, Sri Manakula Vinayagar Medical College Hospital, Puducherry, India.

    CORRESPONDENCE

    Jayanthi Mathaiyan

    Department of Pharmacology, JIPMER, Puducherry, India.

    drjayanthi2008@gmail.com

    Received: 24-12-2020; Revised: 26-12-2020; Accepted: 29-12-2020.

    Volume 11, Issue 4 · pp. 148–150 · PUBLISHED 2020 · DOI: 10.4103/jpp.jpp_173_20

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    KEYWORDS

      Open in new tab

      REFERENCES

      As published

      Showing references and in-text citations exactly as published.

        Cite this article

        SELECT FORMAT

        Mathaiyan, J., Ganesan, P., Kadhiravan, T., & Anandabaskar, N. (2020). Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 148–150. https://doi.org/10.4103/jpp.jpp_173_20